Skip to main content

The AHRQ National Quality Measures Clearinghouse (NQMC, qualitymeasures.ahrq.gov) Web site will not be available after July 16, 2018 because federal funding
through AHRQ will no longer be available to support the NQMC as of that date. For additional information, read our full announcement.
  • Measure Summary
  • NQMC:010886
  • Dec 2009

AIDS Drug Assistance Program (ADAP): percentage of new anti-retroviral classes that are included in the ADAP formulary within 90 days of the date of inclusion of new anti-retroviral classes in the U.S. Public Health Service (PHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents during the measurement year.

Health Resources and Services Administration (HRSA). HAB HIV performance measures. ADAP: AIDS Drug Assistance Program. Rockville (MD): Health Resources and Services Administration (HRSA); 2009 Dec 10. 9 p.

View the original measure documentation External Web Site Policy

This is the current release of the measure.

  • Save

Primary Measure Domain

Population Health Quality Measures: Population Structure

Secondary Measure Domain

Does not apply to this measure

Description

This measure is used to assess the percentage of new anti-retroviral classes that are included in the AIDS Drug Assistance Program (ADAP) formulary within 90 days of the date of inclusion of new anti-retroviral classes in the U.S. Public Heath Service (PHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents during the measurement year.

Rationale

Human immunodeficiency virus (HIV)-related morbidity and mortality has dropped dramatically due to advances in HIV/acquired immune deficiency syndrome (AIDS) treatment. But reductions are uneven across HIV-infected populations due to unequal access to care and variable quality of services provided. Quality management seeks to enhance the quality of HIV care provided and increase access to services. They do so by measuring how health and social services meet established professional standards and user expectations.

The Ryan White HIV Treatment Modernization Act of 2006 (P.L. 109-415) mandates that the state-operated AIDS Drug Assistance Program (ADAP) programs "shall ensure that the therapeutics included on the list of classes of core antiretroviral therapeutics established by the secretary under subsection (e) are, at a minimum, the treatments provided by the state pursuant to this section." All ADAPs must include agents from each of the core antiretroviral classes listed in U.S. Public Heath Service (PHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2009; Hopson, 2007; Hopson, 2008). These legislative and policy requirements have also been specified in the Part B ADAP grant application (Health Resources and Services Administration [HRSA], 2008).

PHS Guidelines

PHS Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2009) contains the list of classes of core antiretroviral therapeutics to be included in ADAP formularies.

Evidence for Rationale

Health Resources and Services Administration (HRSA). Deliver HIV/AIDS care: quality of care. [internet]. Rockville (MD): Health Resources and Services Administration (HRSA); [accessed 2016 Jun 23].

Health Resources and Services Administration (HRSA). HAB HIV performance measures. ADAP: AIDS Drug Assistance Program. Rockville (MD): Health Resources and Services Administration (HRSA); 2009 Dec 10. 9 p.

Health Resources and Services Administration (HRSA). HIV Care Grant Program Part B: states/territories formula and supplemental awards and AIDS Drug Assistance Program formula and supplemental awards: program guidance. Rockville (MD): Health Resources and Services Administration (HRSA); 2008 Nov 4. 6 p.

Hopson DP. HRSA letter to Part B grantees. Rockville (MD): Health Resources and Services Administration (HRSA); 2008 Feb 1.

Hopson DP. Policy notice-07-03: the use of Ryan White HIV/AIDS Program, Part B (formerly Title II), AIDS Drug Assistance Program (ADAP) funds for access, adherence and monitoring services. Rockville (MD): Health Resources and Services Administration (HRSA); 2007 Sep. 4 p.

Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Bethesda (MD): Department of Health and Human Services (DHHS); 2009 Dec 1. 161 p.

The Ryan White HIV Treatment Modernization Act of 2006 (P.L. 109-415), Section 202(a).

Primary Health Components

Human immunodeficiency virus (HIV); AIDS Drug Assistance Program (ADAP); formulary; anti-retroviral classes

Denominator Description

Total number of new antiretroviral classes published in updated U.S. Public Health Service (PHS) guidelines during the measurement year (see the related "Denominator Inclusions/Exclusions" field)

Numerator Description

Number of new anti-retroviral classes included into the AIDS Drug Assistance Program (ADAP) formulary within 90 days of the publication of updated U.S. Public Health Service (PHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents that include new anti-retroviral drug class during the measurement year

Type of Evidence Supporting the Criterion of Quality for the Measure

  • A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence

Additional Information Supporting Need for the Measure

Unspecified

Extent of Measure Testing

Unspecified

State of Use

Current routine use

Current Use

External oversight/State government program

Internal quality improvement

Population health improvement

Measurement Setting

State/Provincial Public Health Programs

Professionals Involved in Delivery of Health Services

Public Health Administrators/Managers

Least Aggregated Level of Services Delivery Addressed

State/Provincial

Statement of Acceptable Minimum Sample Size

Does not apply to this measure

Target Population Age

Does not apply to this measure

Target Population Gender

Does not apply to this measure

Public Health Aims for Quality

Effective

Population-centered

Proactive

National Quality Strategy Aim

Healthy People/Healthy Communities

IOM Care Need

Not within an IOM Care Need

IOM Domain

Not within an IOM Domain

Case Finding Period

The measurement year

Denominator Sampling Frame

Clinical information

Denominator (Index) Event or Characteristic

Does not apply to this measure

Denominator Time Window

Does not apply to this measure

Denominator Inclusions/Exclusions

Inclusions
Total number of new antiretroviral classes published in updated U.S. Public Health Service (PHS) guidelines during the measurement year

Note: Refer to the original measure documentation for additional data elements.

Exclusions
PHS Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents published in the last 90 days of the measurement year

Exclusions/Exceptions

Does not apply to this measure

Numerator Inclusions/Exclusions

Inclusions
Number of new anti-retroviral classes included into the AIDS Drug Assistance Program (ADAP) formulary within 90 days of the publication of updated U.S. Public Health Service (PHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents that include new anti-retroviral drug class during the measurement year

Exclusions
Unspecified

Numerator Search Strategy

Fixed time period or point in time

Data Source

National public health data

State/Province public health data

Type of Health State

Does not apply to this measure

Instruments Used and/or Associated with the Measure

Unspecified

Measure Specifies Disaggregation

Does not apply to this measure

Scoring

Rate/Proportion

Interpretation of Score

Desired value is a higher score

Allowance for Patient or Population Factors

Unspecified

Standard of Comparison

Internal time comparison

Original Title

ADAP: formulary.

Measure Collection Name

HIV/AIDS Bureau (HAB) Performance Measures

Measure Set Name

AIDS Drug Assistance Program

Submitter

Health Resources and Services Administration - Federal Government Agency [U.S.]

Developer

Health Resources and Services Administration - Federal Government Agency [U.S.]

Funding Source(s)

Unspecified

Composition of the Group that Developed the Measure

Unspecified

Financial Disclosures/Other Potential Conflicts of Interest

Unspecifed

Adaptation

This measure was not adapted from another source.

Date of Most Current Version in NQMC

2009 Dec

Measure Maintenance

Unspecified

Date of Next Anticipated Revision

Unspecified

Measure Status

This is the current release of the measure.

Source(s)

Health Resources and Services Administration (HRSA). HAB HIV performance measures. ADAP: AIDS Drug Assistance Program. Rockville (MD): Health Resources and Services Administration (HRSA); 2009 Dec 10. 9 p.

Measure Availability

Source available from the Health Resources and Services Administration (HRSA) Web site External Web Site Policy.

For more information, contact the HRSA HIV/AIDS Bureau (HAB) at 5600 Fishers Lane, Rockville, MD 20857; E-mail: HIVmeasures@hrsa.gov; Web site: www.hrsa.gov/index.html External Web Site Policy.

NQMC Status

This NQMC summary was completed by ECRI Institute on July 8, 2016.

Copyright Statement

No copyright restrictions apply.

NQMC Disclaimer

The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.

All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.

Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the NQMC Inclusion Criteria.

NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding measure content are directed to contact the measure developer.